Macloglymin 500 mg, 850 mg, 1000 mg FC tablets.
PDF Leaflet Revision Date: 27 September 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of type II diabetes mellitus in overweight patients.
Dosage (summary)
Adults: 500 mg three times daily or 850/1000 mg twice daily with meals. Max: 2550 mg/day. Children: 500/850 mg once daily, max 2000 mg/day.
Onset of Action / Duration
Onset: Few days, Duration: Up to 2 weeks for full effect.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or lactation; insulin preferred for diabetes management.
Key Drug Interactions
- Alcohol
- Iodinated contrast agents
- Glucocorticoids
- Beta-2-agonists
- Diuretics
Contraindications
- Hypersensitivity to metformin
- Diabetic ketoacidosis
- Renal failure
- Acute conditions affecting renal function
- Hepatic insufficiency
Common side effects
- Nausea
- Vomiting
- Diarrhoea
- Abdominal pain
- Taste disturbance
Counselling Points
- Take with meals
- Monitor blood glucose regularly
- Avoid alcohol
- Assess vitamin B12 levels annually
Serious warnings
- Risk of lactic acidosis
- Monitor renal function
- Caution in heart failure
Important Disclaimer
The Macloglymin 500 mg, 850 mg, 1000 mg FC tablets. professional information leaflet below is the property of Macleods Pharmaceuticals Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
